Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Role of 3-phase bone scintigraphy [[Unsupported ANSI Character - ]]• FDG-PET to monitor hyperbaric oxygen therapy for several types of refractory osteomyelitis.

Kenichiro Sakata, Takuya Asaka, Noritaka Ohga, Jun Sato, Kenji Hirata, Yuji Kuge, Tohru Shiga and Yoshimasa Kitagawa
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1266;
Kenichiro Sakata
3Oral Diagnosis and medicine, Graduate School of Dental Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Asaka
3Oral Diagnosis and medicine, Graduate School of Dental Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noritaka Ohga
3Oral Diagnosis and medicine, Graduate School of Dental Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Sato
3Oral Diagnosis and medicine, Graduate School of Dental Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Hirata
2Nuclear Medicine, Graduate School of Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Kuge
1Central Institute of Isotope Science Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Shiga
2Nuclear Medicine, Graduate School of Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshimasa Kitagawa
3Oral Diagnosis and medicine, Graduate School of Dental Medicine Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of 3-phase bone scintigraphy [[Unsupported ANSI Character - ]]• FDG-PET to monitor hyperbaric oxygen therapy for several types of refractory osteomyelitis.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of 3-phase bone scintigraphy [[Unsupported ANSI Character - ]]• FDG-PET to monitor hyperbaric oxygen therapy for several types of refractory osteomyelitis.
Kenichiro Sakata, Takuya Asaka, Noritaka Ohga, Jun Sato, Kenji Hirata, Yuji Kuge, Tohru Shiga, Yoshimasa Kitagawa
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1266;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of 3-phase bone scintigraphy [[Unsupported ANSI Character - ]]• FDG-PET to monitor hyperbaric oxygen therapy for several types of refractory osteomyelitis.
Kenichiro Sakata, Takuya Asaka, Noritaka Ohga, Jun Sato, Kenji Hirata, Yuji Kuge, Tohru Shiga, Yoshimasa Kitagawa
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1266;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK
  • SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
  • Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
  • Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
  • Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
  • Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Preliminary Clinical Results for 18F-FDGPET/MR Compared with PET/CT in Patients with Suspected Recurrent or Metastatic Differentiated Thyroid Cancer
  • Clinical value of 99mTc-deoxy-glucose derivative SPECT/CT in tumors
Show more Oncology: Clinical Therapy and Diagnosis

Head and Neck Posters

  • Prognostic value of 18F-FDG PET/CT Imaging in Recurrent Salivary Gland Cancers
  • Is F18-FDG PET useful in Surveillance of Head and Neck Cancer
  • A pilot study for texture analysis of FDG PET/CT for differentiating malignant lymphoma from squamous cell carcinoma in head and neck region
Show more Head and Neck Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire